Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

Rhea-AI Summary

Omega Therapeutics, Inc. (Nasdaq: OMGA) will participate in a fireside chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference on December 6, 2023, at 9:30 a.m. ET. A live webcast will be available on the Investors & Media section of the Company's website at www.omegatherapeutics.com.

CAMBRIDGE, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced that management will participate in a fireside chat at the H.C. Wainwright 4^th Annual Precision Oncology Virtual Conference on Wednesday, December 6, 2023, at 9:30 a.m. ET.

A live webcast of the fireside chat will be available on the Investors & Media section of the Company's website at www.omegatherapeutics.com. An archived replay will be available on the same website for approximately 90 days.

About Omega Therapeutics
Omega Therapeutics is a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines to treat or cure a broad range of diseases. By pre-transcriptionally modulating gene expression, Omega’s approach enables controlled epigenomic modulation of nearly all human genes, including historically undruggable and difficult-to-treat targets, without altering native nucleic acid sequences. Founded in 2017 by Flagship Pioneering following breakthrough research by world-renowned experts in the field of epigenetics, Omega is led by a seasoned and accomplished leadership team with a track record of innovation and operational excellence. The Company is committed to revolutionizing genomic medicine and has a diverse pipeline of therapeutic candidates derived from its OMEGA platform spanning oncology, regenerative medicine, multigenic diseases including immunology, and select monogenic diseases.

For more information, visit omegatherapeutics.com, or follow us on X (formerly Twitter) and LinkedIn.

When will Omega Therapeutics, Inc. participate in the fireside chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference?

Omega Therapeutics, Inc. will participate in the fireside chat on December 6, 2023, at 9:30 a.m. ET.

Where can I watch the live webcast of the fireside chat?

The live webcast will be available on the Investors & Media section of Omega Therapeutics, Inc.'s website at www.omegatherapeutics.com.

Will there be an archived replay of the fireside chat available?

Yes, an archived replay will be available on Omega Therapeutics, Inc.'s website for approximately 90 days.